HHS has sent drug for Ebola clinical trial

AI Summary

The US Department of Health and Human Services has provided a drug for an early-stage clinical trial targeting Ebola, with a single patient receiving retatrutide access. This development is part of ongoing health efforts related to Ebola treatment research.

FDA's early-stage clinical trial program, a mysterious single patient gets retatrutide access, and more health news from Morning Rounds